Quest Diagnostics, Inc.

NYSE:DGX   3:59:57 PM EDT
136.56
+0.17 (+0.12%)
4:00:00 PM EDT: $136.49 -0.07 (-0.05%)
Products

Quest Diagnostics Launches Three New Combined Covid-19 And Respiratory Virus Tests

Published: 09/30/2020 11:50 GMT
Quest Diagnostics, Inc. (DGX) - Quest Diagnostics Launches Three New Combined Covid-19 and Respiratory Virus Tests.
Quest Diagnostics - Healthcare Providers Across U.S. Can Now Access 3 Different Test Options From Quest Diagnostics to Aid Diagnosis of Covid-19.
Quest Diagnostics - New Test Options Include Cobas Sars-cov-2 & Influenza A/b*, Automated High Throughput Multiplex Real-time Rt-pcr Assay From Roche.
Quest Diagnostics Inc - Each Respiratory Panel Test Also Only Requires a Single Nasopharyngeal Specimen.